Involvement of the central melanocortin system in the effects of caffeine on anxiety-like behavior in mice

Life Sciences

Volumn 95, Issue 2, 2014, Pages 72-80

  Bhorkar, Amita A ^a   Dandekar, Manoj P ^a   Nakhate, Kartik T ^b   Subhedar, Nishikant K ^c   Kokare, Dadasaheb M ^a  

^a RTM NAGPUR UNIVERSITY   (India)

^b RUNGTA COLLEGE OF PHARMACEUTICAL SCIENCES AND RESEARCH   (India)

^c INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH   (India)

Author keywords

MSH; Anxiety; Caffeine; Central nucleus of amygdala; Social interaction test

Indexed keywords

ADENOSINE RECEPTOR BLOCKING AGENT; ALPHA INTERMEDIN; BETA INTERMEDIN[11-22][11 (N ACETYLCYSTEINE) 14 [3 (2 NAPHTHYL) DEXTRO ALANINE] 18 CYSTEINE 22 ASPARTIC ACID AMIDE] 11,18 CYCLIC DISULFIDE; CAFFEINE; MELANOCORTIN; MELANOCORTIN 4 RECEPTOR AGONIST; MELANOCORTIN RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ACUTE DRUG ADMINISTRATION; AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; SOCIAL INTERACTION; SOCIAL INTERACTION TEST;

MUS;

ANXIETY; CAFFEINE; CENTRAL NUCLEUS OF AMYGDALA; SOCIAL INTERACTION TEST; Α-MSH;

ALPHA-MSH; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG TOLERANCE; MALE; MICE; PEPTIDES; PEPTIDES, CYCLIC; PROTEIN BINDING; RECEPTORS, MELANOCORTIN;

EID: 84892824122     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.12.014     Document Type: Article

References (97)

1. J. Amat, P. Matus-Amat, L.R. Watkins, and S.F. Maier Escapable and inescapable stress differentially alter extracellular levels of 5-HT in the basolateral amygdala of the rat Brain Res 812 1998 113 120
2. J. Amat, J.P. Tamblyn, E.D. Paul, S.T. Bland, P. Amat, and A.C. Foster et al. Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala Neuroscience 129 2004 509 519
3. H.A. Baldwin, and S.E. File Caffeine-induced anxiogenesis: the role of adenosine, benzodiazepine and noradrenergic receptors Pharmacol Biochem Behav 32 1989 181 186
4. L. Bellocchio, P. Lafenêtre, A. Cannich, D. Cota, N. Puente, and P. Grandes et al. Bimodal control of stimulated food intake by the endocannabinoid system Nat Neurosci 13 2010 281 283
5. S.C. Benoit, M.W. Schwartz, J.L. Lachey, M.M. Hagan, P.A. Rushing, and K.A. Blake et al. A novel selective melanocortin-4 receptor agonist reduces food intake in rats and mice without producing aversive consequences J Neurosci 20 2000 3442 3448
6. S.K. Bhattacharya, K.S. Satyan, and A. Chakrabarti Anxiogenic action of caffeine: an experimental study in rats J Psychopharmacol 11 1997 219 224
7. S.M. Bhisikar, D.M. Kokare, K.T. Nakhate, C.T. Chopde, and N.K. Subhedar Tolerance to ethanol sedation and withdrawal hyper-excitability is mediated via neuropeptide Y Y1 and Y5 receptors Life Sci 85 2009 765 772
8. M.W. Bitensky, and S.R. Burstein Effects of cyclic adenosine monophosphate and melanocyte-stimulating hormone on frog skin in vitro Nature 208 1965 1282 1284
9. A. Blasio, A. Iemolo, V. Sabino, S. Petrosino, L. Steardo, and K.C. Rice et al. Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdala Neuropsychopharmacology 38 2013 2498 2507
10. M. Bourin, and M. Hascoët Drug mechanisms in anxiety Curr Opin Investig Drugs 2 2001 259 265
11. M. Broadwater, E.I. Varlinskaya, and L.P. Spear Chronic intermittent ethanol exposure in early adolescent and adult male rats: effects on tolerance, social behavior, and ethanol intake Alcohol Clin Exp Res 35 2011 1392 1403
12. M.S. Bruce The anxiogenic effects of caffeine Postgrad Med J 66 1990 8 24
13. S. Cabeza de Vaca, G.Y. Kim, and K.D. Carr The melanocortin receptor agonist MTII augments the rewarding effect of amphetamine in ad-libitum fed and food-restricted rats Psychopharmacology (Berl) 161 2002 77 85
14. S. Chaki, S. Hirota, T. Funakoshi, Y. Suzuki, S. Suetake, and T. Okubo et al. Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-flourophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl] -4-[4-(2-methoxynapthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of melanocortin-4 receptor J Pharmacol Exp Ther 304 2003 818 826
15. S. Chaki, S. Ogawa, Y. Toda, T. Funakoshi, and S. Okuyama Involvement of melanocortin MC(4) receptor in stress-related behavior in rodents Eur J Pharmacol 474 2003 95 101
16. S. Chaki, and S. Okuyama Involvement of melanocortin-4 receptor in anxiety and depression Peptides 26 2005 1952 1964
17. S. Chaki, Y. Oshida, S. Ogawa, T. Funakoshi, T. Shimazaki, and T. Okubo et al. MCL0042: a nonpeptidic MC4 receptor antagonist and serotonin reuptake inhibitor with anxiolytic- and antidepressant-like activity Pharmacol Biochem Behav 82 2005 621 626
18. S. Chaki, and T. Okubo Melanocortin-4 receptor antagonists for the treatment of depression and anxiety disorders Curr Top Med Chem 7 2007 1145 1151
19. N. Chartrel, M.C. Tonon, M. Lamcacz, and H. Vaudry Adenosine inhibits α-melanocyte-stimulating hormone release from frog pituitary melanotrophs. Evidence for the involvement of a(1) adenosine receptors negatively coupled to adenylate cyclase J Neuroendocrinol 4 1992 751 757
20. J.P. Christianson, T. Ragole, J. Amat, B.N. Greenwood, P.V. Strong, and E.D. Paul et al. 5-hydroxytryptamine 2C receptors in the basolateral amygdala are involved in the expression of anxiety after uncontrollable traumatic stress Biol Psychiatry 67 2010 339 345
21. T. Cote, M. Munemura, R.L. Eskay, and J.W. Kebabian Biochemical identification of the beta-adrenoceptor and evidence for the involvement of an adenosine 3′,5′-monophosphate in beta-adrenergically induced release of alpha-melanocyte-stimulating hormone in the intermediate lobe of the rat pituitary gland Endocrinology 107 1980 108 116
22. C.M. Cremer, N. Palomero-Gallagher, H.J. Bidmon, A. Schleicher, E.J. Speckmann, and K. Zilles Pentylenetetrazole-induced seizures affect binding site densities for GABA, glutamate and adenosine receptorsin the rat brain Neuroscience 163 2009 490 499
23. M.P. Dandekar, P.S. Singru, D.M. Kokare, R.M. Lechan, L. Thim, and J.T. Clausen et al. Importance of cocaine- and amphetamine-regulated transcript peptide (CART) in the central nucleus of amygdala in anxiogenic responses induced by ethanol withdrawal Neuropsychopharmacology 33 2008 1127 1136
24. M.P. Dandekar, K.T. Nakhate, D.M. Kokare, and N.K. Subhedar Involvement of CART in estradiol-induced anorexia Physiol Behav 105 2012 460 469
25. M. Davis, and C. Shi The extended amygdala: are the central nucleus of the amygdala and the bed nucleus of the stria terminalis differentially involved in fear versus anxiety? Ann N Y Acad Sci 877 1999 281 291
26. C. Delbende, S. Jegou, D. Tranchand-Bunel, C. Blasquez, and H. Vaudry Gamma-aminobutyric acid inhibits the release of alpha-melanocyte-stimulating hormone from rat hypothalamic slices Brain Res 497 1989 86 93
27. J.A. den Boer, and B.R. Slaap Review of current treatment in panic disorder Int Clin Psychopharmacol 13 Suppl. 4 1998 S25 S30
28. G.S. Deo, M.P. Dandekar, M.A. Upadhya, D.M. Kokare, and N.K. Subhedar Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: behavioral and immunocytochemical evidences Brain Res 1318 2010 77 86
29. B.A. Eipper, and R.E. Mains Structure and biosynthesis of proadrenocorticotropin/endorphin and related peptides Endocrinol Rev 1 1980 1 27
30. R.L. Eskay, P. Giraud, C. Oliver, and M.J. Brown-Stein Distribution of alpha-melanocyte-stimulating hormone in the rat brain: evidence that alpha-MSH containing cells in the arcuate region send projections to extrahypothalamic areas Brain Res 178 1979 55 67
31. S.E. File, and P. Seth A review of 25 years of the social interaction test Eur J Pharmacol 463 2003 35 53
32. S.E. File, H.A. Baldwin, A.L. Johnston, and L.J. Wilks Behavioral effects of acute and chronic administration of caffeine in the rat Pharmacol Biochem Behav 30 1988 809 815
33. B.B. Fredholm Purinoceptors in the nervous system Pharmacol Toxicol 769 1995 228 239
34. B. Fredholm, K. Battig, J. Holmen, A. Nehlig, and E. Zvartau Actions of caffeine in the brain with special reference to factors that contribute to its widespread use Pharmacol Rev 51 1999 83 133
35. V. Georgiev, B. Johanson, and B.B. Fredholm Long-term caffeine treatment leads to a decreased susceptibility to NMDA-induced clonic seizures in mice without changes in adenosine A1 receptor number Brain Res 612 1993 271 277
36. L. Gimenez-Llort, A. Fernandez-Teruel, R.M. Escorihuela, B.B. Fredholm, A. Tobena, and M. Pekny et al. Mice lacking the adenosine A1 receptor are anxious and aggressive, but are normal learners with reduced muscle strength and survival rate Eur J Neurosci 16 2002 547 550
37. F.G. Graeff, and H. Zangrossi Jr. The dual role of serotonin in defense and the mode of action of antidepressants on generalized anxiety and panic disorders Cent Nerv Syst Agents Med Chem 10 2010 207 217
38. R.M. Green, and G.L. Stiles Chronic caffeine ingestion sensitizes the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex J Clin Invest 77 1986 222 227
39. M. Hawkins, M.M. Dugich, N. Porter, M. Urbancic, and M. Radulovacki Effects of chronic administration of caffeine on adenosine A1 and A2 receptors in rat brain Brain Res Bull 21 1988 479 482
40. E.J. Hoffman, and S.J. Mathew Anxiety disorders: a comprehensive review of pharmacotherapies Mt Sinai J Med 75 2008 248 262
41. T. Inoue, T. Izumi, X.B. Li, J.Z. Huang, Y. Kitaichi, and S. Nakagawa et al. Biological basis of anxiety disorders and serotonergic anxiolytics Nihon Shinkei Seishin Yakurigaku Zasshi 24 2004 125 131
42. S. Jegou, M.E. Yacoubi, L. Mounien, C. Ledent, M. Parmentier, and J. Costentin et al. Adenosine A2A receptor gene distribution provokes marked changes in melanocortin content and pro-opiomelanocortin gene expression J Neuroendocrinol 15 2003 1171 1177
43. B. Johansson, V. Georgiev, K. Lindstrom, and B.B. Fredholm A1 and A2A adenosine receptors and A1 mRNA in mouse brain: effect of long-term caffeine treatment Brain Res 762 1997 153 164
44. A.S. Kalange, D.M. Kokare, P.S. Singru, M.A. Upadhya, C.T. Chopde, and N.K. Subhedar Central administration of selective melanocortin 4 receptor antagonist HS014 prevents morphine tolerance and withdrawal hyperalgesia Brain Res 1181 2007 10 20
45. G.B. Kalpan, D.J. Greenblatt, M.A. Kent, and M.M. Cotreau-Bibbo Caffeine treatment and withdrawal in mice: relationships between dosage, concentrations, locomotor activity and A1 adenosine receptor biniding J Pharmacol Exp Ther 266 1993 1563 1572
46. A. Kask, L. Rägo, and J. Harro Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226 Br J Pharmacol 124 1998 1507 1515
47. H. Kawahara, M. Yoshida, H. Yokoo, M. Nishi, and M. Tanaka Psychological stress increases serotonin release in the rat amygdala and prefrontal cortex assessed by invivo microdialysis Neurosci Lett 162 1993 81 84
48. T. Kishi, C.J. Aschkenasi, C.E. Lee, K.G. Mountjoy, C.B. Saper, and J.K. Elmquist Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat J Comp Neurol 457 2003 213 235
49. D.J. Knapp, D.H. Overstreet, S.S. Moy, and G.R. Breese SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats Alcohol 32 2004 101 111
50. D.M. Kokare, M.P. Dandekar, C.T. Chopde, and N. Subhedar Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats Brain Res 1043 2005 107 114
51. D.M. Kokare, C.T. Chopde, and N.K. Subhedar Participation of α-melanocyte stimulating hormone in ethanol-induced anxiolysis and withdrawal anxiety in rats Neuropharmacology 51 2006 536 545
52. D.M. Kokare, P.S. Singru, M.P. Dandekar, C.T. Chopde, and N.K. Subhedar Involvement of alpha-melanocyte stimulating hormone (α-MSH) in differential ethanol exposure and withdrawal related depression in rat: neuroanatomical-behavioral correlates Brain Res 1216 2008 53 67
53. D.M. Kokare, G.P. Shelkar, C.D. Borkar, K.T. Nakhate, and N.K. Subhedar A simple and inexpensive method to fabricate a cannula system for intracranial injections in rats and mice J Pharmacol Toxicol Methods 64 2011 246 250
54. S.K. Kulkarni, K. Singh, and M. Bishnoi Involvement of adenosinergic receptors in anxiety related behaviours Indian J Exp Biol 45 2007 439 443
55. C. Ledent, J.M. Vaugeois, S.N. Schiffmann, T. Pedrazzini, M. EI Yacoubi, and J.J. Vanderhaeghen et al. Agressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor Nature 388 1997 674 678
56. B.K. Lim, K.W. Huang, B.A. Grueter, P.E. Rothwell, and R.C. Malenka Anhedonia requires MC4R-mediated synaptic adaptations in nucleus accumbens Nature 487 2012 183 189
57. D.N. Linsenbardt, E.M. Moore, C.D. Gross, K.J. Goldfarb, L.C. Blackman, and S.L. Boehm II Sensitivity and tolerance to the hypnotic and ataxic effects of ethanol in adolescent and adult C57BL/6 J and DBA/2 J mice Alcohol Clin Exp Res 33 2009 464 476
58. C.R. Lupica, R.F. Berman, and M.F. Jarvis Chronic theophylline treatment increases adenosine A1, but not A2, receptor binding in the rat brain: an autoradiographic study Synapse 9 1991 95 102
59. S.F. Maier, and L.R. Watkins Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor Neurosci Biobehav Rev 29 2005 829 841
60. S.S. Manna, and S.N. Umathe Transient receptor potential vanilloid 1 channels modulate the anxiolytic effect of diazepam Brain Res 1425 2011 75 82
61. A. Marowsky, J.M. Fritschy, and K.E. Vogt Functional mapping of GABA A receptor subtypes in the amygdala Eur J Neurosci 20 2004 1281 1289
62. D.B. Matthews, K.L. Tinsley, J.L. Diaz-Granados, S. Tokunaga, and J.M. Silvers Chronic intermittent exposure to ethanol during adolescence produces tolerance to the hypnotic effects of ethanol in male rats: a dose-dependent analysis Alcohol 42 2008 617 621
63. Y.A. Mei, H. Vaudry, and L.C. Cazin Inhibitory effect of adenosine on electrical activity of melanotrophs mediated through A1 purinergic receptor J Physiol 481 1994 349 355
64. Y.A. Mei, F. Le Foll, H. Vaudry, and L. Crazin Adenosine inhibits L- and N-type calcium channels in pituitary melanotrophs. Evidence for the involvement of a G protein in calcium channel gating J Neuroendocrinol 8 1996 85 91
65. D. Mitsushima, K. Yamada, K. Takase, T. Funabashi, and F. Kimura Sex differences in the basolateral amygdala: the extracellular levels of serotonin and dopamine, and their responses to restraint stress in rats Eur J Neurosci 24 2006 3245 3254
66. M. Munemura, R.L. Eskay, and J.W. Kebabian Release of alpha-melanocyte stimulating hormone from dispersed cells of the intermediate lobe of the rat pituitary gland: involvement of catecholamines and adenosine 3′,5′-monophosphate Endocrinology 106 1980 1795 1803
67. F. Naftolin, M. Shanabrough, and C. Leranth Pro-opiomelanocortin (POMC) neurons in the mediobasal hypothalamus (MBH) projecting to the medial preoptic area (MPO) are synaptic targets of GABAergic terminals Soc Neurosci Abstr 393 1990 1
68. K.T. Nakhate, N.K. Subhedar, A.P. Bharne, P.S. Singru, and D.M. Kokare Involvement of cocaine- and amphetamine-regulated transcript peptide in the hyperphagic and body weight promoting effects of allopregnanolone in rats Brain Res 1532 2013 44 55
69. A. Nehlig, J.L. Daval, and G. Debry Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects Brain Res Rev 17 1992 139 170
70. T.L. O'Donohue, R.L. Miller, and D.M. Jacobowitz Identification, characterization and stereotaxic mapping of intraneuronal alpha-melanocyte stimulating hormone like immunoreactive peptides in discrete regions of the rat brain Brain Res 176 1979 101 123
71. D.H. Overstreet, D.J. Knapp, and G.R. Breese Accentuated decrease in social interaction in rats subjected to repeated ethanol withdrawals Alcohol Clin Exp Res 26 2002 1259 1268
72. D.H. Overstreet, D.J. Knapp, S.S. Moy, and G.R. Breese A 5-HT1A agonist and a 5-HT2c antagonist reduce social interaction deficit induced by multiple ethanol withdrawals in rats Psychopharmacology (Berl) 167 2003 344 352
73. G. Paxinos, and K.B. Franklin The mouse brain in stereotaxic coordinates 2001 Academic Press California
74. R.D. Prediger, L.C. Batista, and R.N. Takahashi Adenosine A1 receptors modulate the anxiolytic-like effect of ethanol in the elevated plus-maze in mice Eur J Pharmacol 499 2004 147 154
75. R.D. Prediger, G.E. da Silva, L.C. Batista, A.L. Bittencourt, and R.N. Takahashi Activation of adenosine A1 receptors reduces anxiety-like behavior during acute ethanol withdrawal (hangover) in mice Neuropsychopharmacology 31 2006 2210 2220
76. T.L. Rao, D.M. Kokare, S. Sarkar, R.T. Khisti, C.T. Chopde, and N. Subhedar GABAergic agents prevent alpha-melanocyte stimulating hormone induced anxiety and anorexia in rats Pharmacol Biochem Behav 76 2003 417 423
77. A.N. Sharma, C.T. Chopde, K. Hirani, D.M. Kokare, and R.R. Ugale Chronic progesterone treatment augments while dehydroepiandrosterone sulphate prevents tolerance to ethanol anxiolysis and withdrawal anxiety in rats Eur J Pharmacol 567 2007 211 222
78. D.V. Sheehan, and C.G. Mao Paroxetine treatment of generalized anxiety disorder Psychopharmacol Bull 37 Suppl. 1 2003 64 75
79. D. Shi, and J.W. Daly Chronic effects of xanthines on levels of central receptors in mice Cell Mol Neurobiol 19 1999 719 732
80. D. Shi, O. Nikodijevic, K.A. Jacobson, and J.W. Daly Chronic caffeine alters the density of adenosine, adrenergic, cholinergic, GABA, and serotonin receptors and calcium channels in mouse brain Cell Mol Neurobiol 13 1993 247 261
81. D. Shi, O. Nikodijevic, K.A. Jacobson, and J.W. Daly Effects of chronic caffeine on adenosine, dopamine and acetylcholine systems in mice Arch Int Pharmacodyn Ther 328 1994 261 287
82. T. Shimazaki, and S. Chaki Anxiolytic-like effect of a selective and non-peptidergic melanocortin 4 receptor antagonist, MCL0129, in a social interaction test Pharmacol Biochem Behav 80 2005 395 400
83. L. Spaccapelo, A. Bitto, M. Galantucci, A. Ottani, N. Irrera, and L. Minutoli et al. Melanocortin MCâreceptor agonists counteract late inflammatory and apoptotic responses and improve neuronal functionality after cerebral ischemia Eur J Pharmacol 670 2011 479 486
84. K. Starowicz, I. Obara, R. Przewłocki, and B. Przewlocka Inhibition of morphine tolerance by spinal melanocortin receptor blockade Pain 117 2005 401 411
85. P. Svenningsson, B. Johansson, and B.B. Fredholm Caffeine-induced expression of c-fos mRNA and NGFI-A mRNA in caudate putamen and in nucleus accumbens are differentially affected by the N-methyl-D-aspartate receptor antagonist MK-801 Mol Brain Res 35 1996 183 189
86. P. Svenningsson, and B.B. Fredholm Caffeine mimics the effect of a dopamine D2/3 receptor agonist on the expression of immediate early genes in globus pallidus Neuropharmacology 36 1997 1309 1317
87. P. Svenningsson, G.G. Nomikos, and B.B. Fredholm The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions J Neurosci 19 1999 4011 4022
88. E. Thomas, D. Burock, K. Knudsen, E. Deterding, and E. Yadin Single unit activity in the lateral septum and central nucleus of the amygdala in the elevated plus-maze: a model of exposure therapy? Neurosci Lett 548 2013 269 274
89. K. Varani, F. Portaluppi, S. Merighi, E. Ongini, L. Belardinelli, and A. Borea Caffeine alters A2A adenosine receptors and their function in human platelets Circulation 99 1999 2499 2502
90. J.W. Wang, D.J. David, J.E. Monckton, F. Battaglia, and R. Hen Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells J Neurosci 28 2008 1374 1384
91. C.P. Wayman, and J.F. Wilson Characteristics of NMDA receptors that stimulate release of hypothalamic alpha-MSH Neuroreport 2 1991 481 484
92. C.P. Wayman, N.V. Pike, and J.F. Wilson N-methyl-D-aspartate (NMDA) stimulates release of alpha-MSH from the rat hypothalamus through release of nitric oxide Brain Res 666 1994 201 206
93. P.H. Wu, and V.L. Coffin Up-regulation of brain [3H]diazepam binding sites in chronic caffeine-treated rats Brain Res 294 1984 186 189
94. P.H. Wu, and J.W. Phillis Up-regulation of brain [3H]diazepam binding sites in chronic caffeine treated rats Gen Pharmacol 17 1986 501 503
95. Y. Yamano, M. Yoshioka, Y. Toda, Y. Oshida, S. Chaki, and K. Hamamoto et al. Regulation of CRF, POMC and MC4R gene expression after electrical foot shock stress in the rat amygdala and hypothalamus J Vet Med Sci 66 2004 1323 1327
96. J.M. Zanoveli, M.C. Carvalho, J.M. Cunha, and M.L. Brandão Extracellular serotonin level in the basolateral nucleus of the amygdala and dorsal periaqueductal gray under unconditioned and conditioned fear states: an in vivo microdialysis study Brain Res 1294 2009 106 115
97. J.M. Zanoveli, R.L. Pobbe, V.C. de Bortoli, M.C. Carvalho, M.L. Brandão, and H. Zangrossi Jr. Facilitation of 5-HT1A-mediated neurotransmission in dorsal periaqueductal grey matter accounts for the panicolytic-like effect of chronic fluoxetine Int J Neuropsychopharmacol 13 2010 1079 1088